BLOC1S2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.80130000202195E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.405540E-04 |
Normal-vs-Stage2 |
2.225200E-04 |
Normal-vs-Stage3 |
3.662700E-03 |
Normal-vs-Stage4 |
9.635700E-02 |
Stage1-vs-Stage2 |
1.055980E-02 |
Stage1-vs-Stage3 |
5.101600E-01 |
Stage1-vs-Stage4 |
4.493800E-01 |
Stage2-vs-Stage3 |
1.191000E-01 |
Stage2-vs-Stage4 |
6.322000E-01 |
Stage3-vs-Stage4 |
5.595200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.14099999956896E-07 |
Normal-vs-AfricanAmerican |
1.771590E-04 |
Normal-vs-Asian |
5.176400E-02 |
Caucasian-vs-AfricanAmerican |
7.224600E-01 |
Caucasian-vs-Asian |
1.704620E-01 |
AfricanAmerican-vs-Asian |
5.274400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.84020000004725E-06 |
Normal-vs-Female |
2.1273000028188E-08 |
Male-vs-Female |
1.063990E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.988400E-04 |
Normal-vs-Extreme_Weight |
3.59739999999942E-05 |
Normal-vs-Obese |
1.616780E-04 |
Normal-vs-Extreme_Obese |
3.497800E-01 |
Normal_Weight-vs-Extreme_Weight |
7.206400E-01 |
Normal_Weight-vs-Obese |
5.943200E-01 |
Normal_Weight-vs-Extreme_Obese |
3.973600E-01 |
Extreme_Weight-vs-Obese |
8.135800E-01 |
Extreme_Weight-vs-Extreme_Obese |
4.100200E-01 |
Obese-vs-Extreme_Obese |
4.634400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.293700E-02 |
Normal-vs-Age(41-60Yrs) |
3.89010000000356E-05 |
Normal-vs-Age(61-80Yrs) |
5.56600000534146E-08 |
Normal-vs-Age(81-100Yrs) |
1.486420E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.505600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.363600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.301000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.145800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.482800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.645000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.74550000004081E-06 |
Normal-VS-Type2 PRCC |
5.54019999999822E-05 |
Normal-VS-KIRP CIMP |
3.000900E-03 |
Normal-VS-Unclassified PRCC |
1.003310E-04 |
Type1 PRCC-VS-Type2 PRCC |
5.181800E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.716550E-03 |
Type1 PRCC-VS-Unclassified PRCC |
3.088000E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.217710E-02 |
Type2 PRCC-VS-Unclassified PRCC |
6.628600E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.111800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.019600E-04 |
Normal-vs-N1 |
1.917050E-03 |
Normal-vs-N2 |
4.265600E-01 |
N0-vs-N1 |
3.457600E-01 |
N0-vs-N2 |
9.579200E-01 |
N1-vs-N2 |
7.328600E-01 |
|
|